Your browser doesn't support javascript.
loading
The cannabinoid antagonist, AM251 attenuates ataxia related deficiencies in a cerebellar ataxic model.
Ranjbar, Hoda; Soti, Monavareh; Kohlmeier, Kristi A; Sheibani, Vahid; Ahmadi-Zeidabadi, Meysam; Rafiepour, Kiana; Shabani, Mohammad.
Affiliation
  • Ranjbar H; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
  • Soti M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
  • Kohlmeier KA; Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Sheibani V; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
  • Ahmadi-Zeidabadi M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
  • Rafiepour K; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
  • Shabani M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
Int J Neurosci ; : 1-8, 2022 Sep 30.
Article in En | MEDLINE | ID: mdl-36120979
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Neurosci Year: 2022 Document type: Article Affiliation country: Iran Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Neurosci Year: 2022 Document type: Article Affiliation country: Iran Country of publication: United kingdom